Cargando…
BRCA immunohistochemistry for screening of BRCA mutation in epithelial ovarian cancer patients
To evaluate BRCA1/2 immunohistochemistry (IHC) as a screening test for germline BRCA1/2 in epithelial ovarian cancer (EOC), tumor tissue from 105 EOC patients who had germline BRCA mutations, including 9 BRCA1 mutations, 6 BRCA2 mutations and 90 no BRCA mutations, were studied. Paraffin-embedded tis...
Autores principales: | Manchana, Tarinee, Tantbirojn, Patou, Pohthipornthawat, Natkrita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276421/ https://www.ncbi.nlm.nih.gov/pubmed/32529018 http://dx.doi.org/10.1016/j.gore.2020.100582 |
Ejemplares similares
-
BRCA mutation in high grade epithelial ovarian cancers
por: Manchana, Tarinee, et al.
Publicado: (2019) -
Surgical management of ovarian tumors without the support of intraoperative pathology readings in Bhaktapur Cancer Hospital
por: Marinone, Michelle, et al.
Publicado: (2020) -
Patients’ self-reported factors influencing cervical cancer screening uptake among HIV-positive women in low- and middle-income countries: An integrative review
por: Kasraeian, Maryam, et al.
Publicado: (2020) -
Conventional radiotherapy planning of cervical cancer in resource-constrained set-up: Utilizing soldering lead wire to delineate radiotherapy portal
por: Vinay Kumar, Ramaiah
Publicado: (2020) -
A prognostic study of patients with cervical cancer and HIV/AIDS in Bangkok, Thailand
por: Thokanit, Nintita Sripaiboonkij, et al.
Publicado: (2020)